Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
price controls
Pharma
Alzheimer's Association slams Biogen's $56K Aduhelm list price
Biogen's $56K list price for Alzheimer's drug Aduhelm slammed by patient advocacy group, calling it "simply unacceptable."
Noah Higgins-Dunn
Jun 14, 2021 11:06am
U.K. Labour Party wants government to build manufacturing
Sep 25, 2019 11:42am
Trump seeks order for 'favored-nation' clause on drug prices
Jul 8, 2019 9:43am
Allergan's patent move threatens next industry firestorm
Sep 11, 2017 11:47am
Pfizer appeals record fine from U.K. regulator tied to price hike
Feb 15, 2017 10:22am
GSK gets asthma med Nucala past England's cost watchdogs
Dec 1, 2016 11:33am
